The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Atomoxetine Accord 40 mg Hard Capsules

40 milligram(s) Capsule, hard

Accord Healthcare Ireland Ltd.PA2315/019/004

Main Information

Trade NameAtomoxetine Accord 40 mg Hard Capsules
Active SubstancesAtomoxetine hydrochloride
Strength40 milligram(s)
Dosage FormCapsule, hard
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/019/004

Group Information

ATC CodeN06BA09 atomoxetine


Licence Issued14/01/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

« Back